Expertise in
2
conditions

Tie W. Chong

No. 157, West Five Road, 
Xi'an, CN 
Expertise in
2
conditions
No. 157, West Five Road, 
Xi'an, CN 
OverviewLocationsClinical Research

Overview

Tie Chong practices in Xi'an, China. Chong is highly rated in 2 conditions, according to our data. Their top areas of expertise are Renal Cell Carcinoma (RCC), Urethral Stricture, Prostate Cancer, Nephrectomy, and Sacral Nerve Stimulation.

Their clinical research consists of co-authoring 127 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

No. 157, West Five Road, Xi'an, 710000, China
Other Locations
No. 157 Xiwu Road, Xi'an, 710004, China
157 West Fifth Road, Xi'an, 710000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Fuzuloparib+Abiraterone Acetate+Prednisone
Study Phase: Phase 3

127 Total Publications

Robot-assisted laparoscopic pelvic lymph node dissection for high-risk prostate cancer: Status quo and re-recognition of the strategy
Robot-assisted laparoscopic pelvic lymph node dissection for high-risk prostate cancer: Status quo and re-recognition of the strategy
Journal: Zhonghua nan ke xue = National journal of andrology
Published: August 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chong's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile